Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 5Lung Neoplasms 3Anxiety Disorders 3Solitary Pulmonary Nodule 2Paresthesia 2Multiple Pulmonary Nodules 2Hypesthesia 2Dyspnea 2Depression 2Brain Neoplasms 2Surgical Wound Infection 1Skin Neoplasms 1Radiation Injuries 1Pulmonary Atelectasis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Postoperative Complications 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia 1Inflammatory Bowel Diseases 1Hypoxia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Temozolomide 162Radiosurgery 115Radiotherapy 100Bevacizumab 96Magnetic Resonance Spectroscopy 65Carboplatin 48Etoposide 34pembrolizumab 33Surgical Procedures, Operative 33Irinotecan 33Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 30Carmustine 28Lomustine 25Cisplatin 25Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × Oxygen × Clear all
NCT05904704 2025-11-14

Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors

OHSU Knight Cancer Institute

Phase NA Withdrawn
CNS

Brain Neoplasms

NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

OHSU Knight Cancer Institute

Phase 2 Recruiting
50 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡